Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

Graph Blockchain $GBLC.ca Applauds Shareholder #Datametrex AI Limited $DM.ca for Their Response to the #Covid19 Pandemic

Posted by AGORACOM-JC at 8:56 AM on Friday, April 17th, 2020
  • President & COO, Christian Scovenna added: “On behalf of the executive team and our Board of Directors of the company, we commend and applaud our minority shareholder Datametrex and their entire team for securing the rights globally to import COVID-19 test kits.
  • For many businesses and sectors facing unprecedent times, Datametrex has stepped up as a business leader in helping Canadians during this crisis.”

Toronto, Ontario–(April 17, 2020) – Graph Blockchain Inc. (CSE: GBLC) (“Graph” or “Company“) applauds Datametrex Limited (TSXV: DM) (FSE: D4G) (minority interest shareholder of 26% of the Company) for securing the rights to import COVID-19 detection kit into Canada and other countries around the globe. See Press Release dated April 16, 2020 Health Canada must approve these COVID-19 test kits before they can be used in Canada. Datametrex is currently working with Health Canada to have the approval of these kits fast-tracked.

President & COO, Christian Scovenna added: “On behalf of the executive team and our Board of Directors of the company, we commend and applaud our minority shareholder Datametrex and their entire team for securing the rights globally to import COVID-19 test kits. For many businesses and sectors facing unprecedent times, Datametrex has stepped up as a business leader in helping Canadians during this crisis.”

“We strongly believe these kits will assist Canada in slowing the spread of COVID-19 and ultimately save lives. It’s incredibly rewarding for us to be able to help Canada combat the spread of COVID-19,” said Andrew Ryu, chairman of the company.

These test kits are currently in use in some European and Asian countries outside of South Korea. Approval work has commenced with the Food and Drug Administration (FDA) in the United States to obtain FDA approval and to authorize the tests under the emergency use authorization program run by U.S. Center for Disease Control (CDC).

The Company will be updating the market and its shareholders over the next week(s) with a corporate update.

The Company is not making any express or implied claims that it has the ability to treat the Covid-19 virus at this time.

About Graph Blockchain Inc.

The Company develops leading-edge private blockchain business intelligence and data management solutions that it will implement into a blockchain supported e-commerce marketplace for the sale of psychedelic and ancillary products in legal jurisdictions.

Additional Information on the Company is available at: www.graphblockchain.com

About Datametrex AI Limited.

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Govinda Butcher – CEO
Phone: (416) 522-6688
Email: [email protected]

OR

Christian Scovenna – President & COO
Phone: (416) 453-4708
Email: [email protected]

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Such statements may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/54559

Tags: , , , , ,
Posted in Datametrex AI Limited | Comments Off on Graph Blockchain $GBLC.ca Applauds Shareholder #Datametrex AI Limited $DM.ca for Their Response to the #Covid19 Pandemic

Empower Clinics $CBDT.ca Announces Closing of Private Placement the Launch of Immune System Tele-Medicine Services and Patient Visits Up 480% $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:22 AM on Friday, April 17th, 2020

Empower Clinics closes private placement of $653,000.00 to support the Company growth plan and goes live with physician based immune boosting tele-medicine consultations with online professional supplement dispensing

  • Recently announced digital health initiative, has added physician based tele-medicine consultations to address immune system boosting requirements for existing patients and new patients, on a nationwide basis
  • The Company clinics have also seen a 480% increase in patient visits in the first half of April 2020

VANCOUVER, BC / April 17, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company”), a vertically integrated life sciences company, is pleased to announce the closing of its non-brokered private placement of an aggregate of 16,325,000 units of the Company (each, a “Unit”) at a price of $0.04 per Unit for gross proceeds of $653,000.00 (the “Offering”).

The proceeds of the Offering are expected to be used by the Company for general working capital and corporate purposes.

The Company, as part of the recently announced digital health initiative, has added physician based tele-medicine consultations to address immune system boosting requirements for existing patients and new patients, on a nationwide basis. The Company clinics have also seen a 480% increase in patient visits in the first half of April 2020.

“Securing additional capital provides our Company more flexibility to support our staff and patients, during such a difficult time in history”, said Steven McAuley, Chairman & CEO. “We are hiring physicians and administrative staff right now to meet patient demand and adding technology resources to ensure our new services are available nationwide.”

In addition, our network of physicians will now be able to dispense over 250 premium supplement products to support patients’ needs, through a new online Sun Valley Health supplement store.

“Our new telemedicine platform is extremely robust, giving us the opportunity to provide a variety of modalities to our patients.” said Dustin Klein, Director and SVP Business Development. “We are focused on helping patients boost their immune systems and reduce stress and anxiety that may arise with isolation and social distancing.”

Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.10 per Warrant Share for a period of two years following the Closing.

The Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the “Securities”), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings. None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company operating a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has its first hemp-derived CBD extraction facility under development, to produce proprietary lines of cannabidiol (CBD) based products to distribute through company owned and franchised clinics, wholesale partnerships, online channels and developing retail channels nationwide in the U.S.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

Investors: Dustin Klein
Director
dustin@svmmjcc,com
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , ,
Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Announces Closing of Private Placement the Launch of Immune System Tele-Medicine Services and Patient Visits Up 480% $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

NORTHBUD $NBUD.ca – Ontario online #pot orders hit high, keep steady amid coronavirus-related stockpiling $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:02 PM on Thursday, April 16th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Ontario online pot orders hit high, keep steady amid coronavirus-related stockpiling

  • Cannabis stockpiling in Ontario led to some heavy sales last month, and early signs show that the demand may be sticking around.
  • Data provided by the Ontario Cannabis Store showed daily online orders hovered in the mid-2,000 range for the first half of last month, tripling when Canada moved to restrict U.S. border access and spiking to a high of nearly 14,000 when Ontario announced pot shops would be a non-essential business, requiring their temporary closure.

Ontario online pot orders hit high, keep steady amid coronavirus-related stockpiling 

Cannabis stockpiling in Ontario led to some heavy sales last month, and early signs show that the demand may be sticking around. Data provided by the Ontario Cannabis Store showed daily online orders hovered in the mid-2,000 range for the first half of last month, tripling when Canada moved to restrict U.S. border access and spiking to a high of nearly 14,000 when Ontario announced pot shops would be a non-essential business, requiring their temporary closure. Two weeks later, daily sales have held steady around the 9,000 level, almost five times the amount made prior to the start of the pandemic. While it may be too early to really gauge how COVID-19 will impact legal cannabis sales over the long term, the OCS numbers provide a highly precise glimpse at how people are consuming cannabis during the pandemic.

Source: links.mkt2011.com/servlet/MailView?ms=MzIxMzM4MzQS1&r=MjU5OTkyNTIyMjg1S0&j=MTY4MzcwMDAwMwS2&mt=1&rt=0

Tags: , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Ontario online #pot orders hit high, keep steady amid coronavirus-related stockpiling $CGC $ACB $APH $CRON.ca $OGI.ca

Datametrex $DM.ca Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea

Posted by AGORACOM-JC at 7:15 AM on Thursday, April 16th, 2020
  • Entered into an agreement on April 13, 2020 securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada
  • Under the terms of this agreement, Datametrex was also given rights to sell the tests into other countries around the globe, including the United States
  • iONEBIO Inc. claims their test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy

TORONTO, April 16, 2020  — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to announce that entered into an agreement on April 13, 2020 securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada, Under the terms of this agreement, Datametrex was also given rights to sell the tests into other countries around the globe, including the United States. Datametrex has developed strong relationships with many large multi-national companies in South Korea.  As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.

The COVID-19 test kits are manufactured by iONEBIO INC. in South Korea, and are the same test kits that have been successfully used in South Korea in their “drive-through” testing stations. This kit has also been used to test every traveller entering into South Korea and those testing positive for Covid-19 were immediately isolated.  Datametrex believes a key factor that allowed South Korea to slow the spread of COVID-19 was its ability to swiftly identify and quarantine those infected by testing millions of people using these test kits  These test kits were first approved for use by the Korean Ministry of Food and Drug Safety on August 30, 2019.  In addition, an independent study was conducted by DankukUniversity (DKU) in Seoul, South Korea, and it was completed and approved on April 2, 2020.

Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company is currently working with Health Canada to have the approval of these kits fast tracked.  These test kits are currently in use in some European and Asian countries outside of South Korea. Approval work has commenced with the FDA in the United States to obtain FDA approval and to authorize the tests under the Emergency Use Authorization Program run by US Center for Disease Control (CDC).

iONEBIO Inc. claims their test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy. Each kit contains 288 individual tests, all of which can be completed in one hour. By utilizing these kits, screening stations can be set up almost anywhere and will allow for the early detection and swift quarantine of infected persons, which is believed to be a key factor in slowing the spread of the novel coronavirus.  Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

South Korea has used this kit to test millions of its citizens and, as of April 14, 2020, there have been 10,654 cases of Covid-19 and 222 deaths reported. In North America, where the use of a rapid test has not been implemented on a large scale, there have been, as at April 14, 2020, 25,680 cases and 780 deaths in Canada and 588,465 cases and 23,711 death in the US.  (All data collected by Datametrex’s Covid-19 dashboard, which is available at http://www.datametrex.com/covid-board.html)

“We strongly believe these kits will assist Canada in slowing the spread of Covid-19 and ultimately save lives. It’s incredibly rewarding for us to be able to help Canada combat the spread of COVID-19,” said Andrew Ryu, Chairman of the Company.

If the test kits are approved by Health Canada and the Canadian government purchases these test kits as expected, the Canadian government will be required to pay the kits in advance. Datametrex expects that all of its costs and expenses related to the import of these tests will be satisfied out of the purchase price for the tests paid for by the Canadian government.

The Company is not making any express or implied claims that it has the ability to treat the Covid-19 virus at this time.

About Datametrex AI Limited

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens- Co-Founder
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea

North Bud Farms Fuels California Growth $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:23 PM on Wednesday, April 15th, 2020
  • Fueled its California growth with the execution of definitive agreements for a master lease, operations and royalty arrangement with an experienced California-licensed operator
  • To operate the licensed facilities at the Company’s Salinas, California farm
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value

TORONTO, April 15, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its U.S. subsidiary, Bonfire Brands USA Inc., has fueled its California growth with the execution of definitive agreements (the “Agreements”) for a master lease, operations and royalty arrangement with an experienced California-licensed operator (the “Cultivator”), to operate the licensed facilities at the Company’s Salinas, California farm.

Highlights of the California Deal

  • Partnering with a proven licensed cannabis cultivator who has been operating successfully in Salinas for several years;
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value;
  • Reduces the Company’s capital expenditure requirements while still generating significant revenue and retaining a portion of the unlimited upside potential through a royalty agreement;
  • Builds EBITDA-positive operations; and
  • Access to a cost-efficient and reliable supply chain on which to build the Company’s branded product portfolio within the state of California.

Terms of the Agreement
As per the terms of the Agreements, the Cultivator will lease the Company’s Salinas farm for 5 years, with options to extend the lease for up to an additional 5 years, and Bonfire Brands USA Inc. will receive the following consideration:

  • Lease payments of USD$900,000 per year, with incremental increases if the Cultivator extends the lease beyond the initial 5 year term;
  • A royalty equal to 5% of the gross revenue generated by the Cultivator from its use of the Salinas farm; and
  • The right to acquire a significant portion of the product harvested each quarter on the farm by the Cultivator, at a 15% discount to market rate.

During the term of the Agreements, the Cultivator will be responsible for the costs of operating the farm, including but not limited to staffing, operations, repair, maintenance, licensing and compliance; moreover, the Cultivator is committed to funding and managing the build-out of up to an additional 230,000 sq. ft. of licensed cultivation space in order to maximize the revenue-generating potential of the property.

“We are very pleased to have concluded this deal as we partner with an established operator to build up our asset and to secure access to high-quality, low-cost cannabis,” said Justin Braune, President of Bonfire Brands USA. “This deal will allow the Company to immediately achieve EBITDA-positive operations at our largest facility without incurring significant capital investments. By retaining preferential purchasing terms, the Company can now focus on the success of its branded product lines, on the back of the estimated 40,000 pounds of production capacity that the Cultivator is expected to bring online over the next 24 months.”

About North Bud Farms Inc.
NORTHBUD owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada. Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution. Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, the success of its arrangement with the Cultivator to lease and operate its Salinas farm, U.S. and Canadian strategies, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]           

Tags: , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms Fuels California Growth $CGC $ACB $APH $CRON.ca $OGI.ca

VIDEO: $HPQ.ca Silicon Launches Missile At Graphite, With Potential To Replace Graphite In Lithium-Ion Batteries $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 5:36 PM on Wednesday, April 15th, 2020

There is no other way to say it.  HPQ Silicon (HPQ:TSXV) just took a direct shot at graphite by stating Silicon Material Produced With It’s Process Offers Promising Potential to Replace Graphite in Lithium-ion Batteries.

The statement is sure to draw significant fire from the multitude of graphite juniors and proponents of graphite as the primary material in the lithium-ion anode, who vastly outnumber the number of silicon proponents in the junior market.  

According to HPQ CEO, Bernard Tourillon, graphite anodes are consistent performers, however, their limited energy capacity makes them ill-suited as the long term global answer to skyrocketing demand for electric vehicles. Silicon anodes, on the other hand, absorb far more lithium than their graphite counterparts, offering a substantial improvement in battery efficiency.

Tourillon isn’t just spinning a story.  His claims are backed by hard facts and science.  He does agree, however, that Silicon has not been able to go mainstream due to swelling and cracking issues – but according to HPQ – these latest promising results represent a step forward in that solving that problem.  

With HPQ already under NDA with a battery manufacturer, Tourillon’s claims carry even greater weight.  If HPQ can deliver, he may very well knock graphite off its perch single-handedly.  

Watch this interview to hear what Tourillon has to further say on the subject, which will also undoubtedly serve as the basis for heated debate between HPQ and the graphite world for months to come.  To the winner the spoils …. and Tourillon believes strongly that HPQ will prevail.  

Ding Ding.  Let the battle begin.

Tags: , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, HPQ-Silicon Resources Inc. | Comments Off on VIDEO: $HPQ.ca Silicon Launches Missile At Graphite, With Potential To Replace Graphite In Lithium-Ion Batteries $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

With greater acceptance and understanding, people know more than ever about #CBD – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 3:55 PM on Wednesday, April 15th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated cannabis company with products in 220 California dispensaries and joint ventures, licensing agreement & partnerships with global brands. The company recently closed $20 MILLION deal with Venom Extracts adding $CDN 16.4 million in revenue and $CDN 2.48 million in EBITDA. Learn More

With greater acceptance and understanding, people know more than ever about CBD. But did you know these five fascinating facts?

  • As research continues to grow, so too does the demand for CBD products
  • So much so, in fact, that the market has yielded some impressive profits in the two years since the Farm Bill was passed; which effectively legalised hemp and CBD at the federal level

By: Michael Turner

With all the hype surrounding CBD, there’s plenty of information to be had on the compound. Derived from hemp, CBD is one of 113 cannabinoids found in cannabis. Each cannabinoid interacts with our body in a specific way, and we even have specialised receptors in our nervous system to accept them.

As research continues to grow, so too does the demand for CBD products. So much so, in fact, that the market has yielded some impressive profits in the two years since the Farm Bill was passed; which effectively legalised hemp and CBD at the federal level.

Whatever you might know about CBD, there’s a good chance you don’t know these five facts. Keep reading to learn what they are, they might just surprise you.

1. It’s One Of The Fastest-Growing Industries In History: You can buy pharmaceutical grade CBD oil in stores and at several online providers all over the country. This massive spread of CBD products is due to the incredible demand for CBD and CBD-based products; causing the industry to become one of the fastest-growing in history.

Financial experts have predicted that the CBD industry has grown at around 107% per-year, and will continue to do so for the better half of the decade. People simply love CBD products, and as researchers discover more amazing benefits, the demand only grows.

The CBD industry managed to surpass the one billion dollar mark last year, and is projected to surpass 10-20 billion in the next few years. As misinformation and stigma dissipate, facts and scientific data take their place, making cannabis, hemp, and CBD better understood by everyone.

2. It Can Help Cancer Patients Manage Symptoms: CBD offers some very promising results in cancer patients. Cancer is a devastating condition where cells divide uncontrollably and destroy tissue. This can include muscle tissue, organs, blood vessels, and more. Often, cancer is incredibly painful, and the treatments available for cancer are no less uncomfortable than the disease itself.

Cannabinoids may actually help with more than just the symptoms of cancer, however. Certain studies have shown that cannabinoids, including CBD, might actually help to slow the growth of tumours. Another study found that it could potentially make cancerous cells more susceptible to radiation while not affecting healthy cells.

Overall, it would seem that CBD has the ability to inhibit cancer growth, manage symptoms, and aid in the destruction of cancerous cells. These are all great things, but further research must be conducted before these benefits can be cemented into CBD’s repertoire.

3. There’s a CBD-Based Drug Available for Seizures: Believe it or not, the FDA itself has recognised and performed research on the effectiveness of CBD in treating certain conditions, and recently approved a drug called Epidiolex, which is formulated from CBD. This breakthrough in CBD research proves that CBD is both useful and effective in medical applications.

Epidiolex is used to treat certain severe forms of epilepsy, such as Dravet Syndrome. These rare conditions can cause debilitating and often dangerous seizures. The CBD-based drug seems to reduce the number of as well as the severity of these seizures, making life more comfortable and manageable for those suffering from these conditions.

4. CBD Is Opening New Doors In Medical Research: Besides treating epilepsy and cancer, CBD is opening doors to all kinds of new research. Studies have been conducted on the compound’s effectiveness at treating or affecting conditions such as anxiety; depression; PTSD; diabetes; heart disease; high blood pressure; skin conditions; Alzheimer’s and more.

According to the Penguin CBD team, now that CBD and hemp are officially legalised, there’s plenty of room for more research and plenty of money in the industry to support new studies. With specialised receptors for cannabinoids in our nervous systems, it’s clear that our bodies are somewhat designed to accept and make use of cannabinoids, and their incredible list of benefits only continues to grow as we learn more.

CBD has yet another useful application: helping to treat addiction. Opioid-based painkillers are the cause of thousands of overdoses and deaths each year, and yet, they’re continuously prescribed without any valid alternatives available. CBD is effective at pain management but has also been shown to reduce the symptoms of withdrawal and help reduce cravings in addicts.

5. CBD Can Be Used In Pets And Children: You probably didn’t know you could give your furry friend CBD, did you? CBD pet treats are available for pets who suffer from chronic pain, inflammation, anxiety, or even have appetite problems. They’re tasty and you’re pet won’t know that they contain anything other than that yummy steak flavour they love so much!

Pet owners all over the country are choosing CBD oil to bring their pets easy comfort and relief from conditions like arthritis. While the research on pets and CBD is scarce, millions of pet owners swear by CBD and its effectiveness.

You can also give CBD to your children. In fact, there are studies available that suggest CBD may be an effective treatment for ADHD instead of giving stimulants to your child. That’s not to say you should immediately replace your child’s ADHD medication with CBD, but you can certainly talk with your child’s doctor about this natural alternative. Many parents have found CBD to be effective at managing hyperactive children and those with focus or concentration issues.

Children also suffer from chronic pain, inflammation, and conditions such as anxiety. CBD is truly an amazing compound with a myriad of useful applications, and it spans beyond just use in adults and humans. Your pets and your children can experience its benefits as well.

CBD is only growing in popularity, and you can be sure to see some more amazing benefits discovered as more money and effort go into CBD studies. With CBD’s legal status solidified, it’s not much easier to study its effects and perform clinical trials without the threat of government interference. Where will the future of CBD and CBD products will take us? The road ahead is set to be an exciting one…

Source: https://www.we-heart.com/2020/04/13/five-things-you-didnt-know-about-cbd/

Tags: , , , ,
Posted in Hollister Biosciences | Comments Off on With greater acceptance and understanding, people know more than ever about #CBD – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Deepfakes 2.0: The New Era of “Truth Decay” – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 1:27 PM on Wednesday, April 15th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation Click here for more info.

Deepfakes 2.0: The New Era of “Truth Decay”

  • Truth is under attack
  • In this post-truth environment, one person’s truth is no longer another’s truth, and information can be weaponized to cause financial or even reputational harm
by Brig. Gen. R. Patrick Huston and Lt. Col. M. Eric Bahm 

“An unexciting truth may be eclipsed by a thrilling lie.” — Aldous Huxley

Deepfake technology has exploded in the last few years. Deepfakes use artificial intelligence (AI) “to generate, alter or manipulate digital content in a manner that is not easily perceptible by humans.” The goal is to create digital video and audio that appears “real.” A picture used to be worth a thousand words – and a video worth a million – but deepfake technology means that “seeing” is no longer “believing.”  From fake evidence to election interference, deepfakes threaten local and global stability.

The first generation (Deepfakes 1.0) was largely used for entertainment purposes. Videos were modified or made from scratch in the pornography industry and to create spoofs of politicians and celebrities. The next generation (Deepfakes 2.0) is far more convincing and readily available. Deepfakes 2.0 are poised to have profound impacts. According to some technologists and lawyers who specialize in this area, deepfakes pose “an extraordinary threat to the sound functioning of government, foundations of commerce and social fabric.”

The Scope of the Problem

Truth is under attack. In this post-truth environment, one person’s truth is no longer another’s truth, and information can be weaponized to cause financial or even reputational harm. While the harmful use of (mis)information has been around for centuries, technology now allows this to happen at a speed and scale never before seen.  With the proliferation of technology, a teenager sitting at home can create and distribute a high-quality deepfake video on her smartphone in a single afternoon. According to Matthew Turek, a program manager for the Defense Advanced Research Projects Agency (DARPA), “We don’t know where this is going to end. We may be headed toward a zero trust environment.”

Criminals could use deepfakes to defraud victims, manipulate markets, and submit false evidence to courts. Authoritarian governments could use deepfakes to target public opinion and foreign adversaries could use them to erode trust in governments. The proliferation of Deepfake 2.0 technology allows this to be done easily, cheaply, and on a grand scale. RAND recently called this “truth decay.” In fact, the mere idea that this technology could be used to manipulate public opinion is already causing some to start questioning the validity of real events and un-doctored video.

Imagine the following possibilities:

  • Fake Evidence: Manipulated videos being used as evidence in court.
  • Sparking a war: a fake video of Israeli soldiers physically assaulting a Palestinian child could spark a new wave of violence in Israel.
  • Manipulating Markets: fake videos of a CEO used to disrupt an initial public offering.
  • Creating Political Fissures: fake videos intended to sow discord between foreign allies.
  • Influencing Elections: A doctored video of a politician looking sick designed to tip the scales of an election.

Deepfakes 2.0 pose a massive threat for the United States and other Western democracies that value truth, individual liberties, and the independence of the media.

Solutions — A Holistic Framework

How do we prepare for this new era of disruptive technology? It will take a whole of society approach where government, academia, and corporations work collaboratively with international partners and individual citizens. This comprehensive method recognizes that each sector possesses unique strengths, capabilities, and limitations. Finland is widely viewed as the gold standard for this approach in confronting sophisticated disinformation efforts. In 2014, the Finnish elections were the target of a disinformation campaign widely attributed to Russia.  The Finnish government took note and began to aggressively formulate a national strategy, including a national education initiative.  The Finnish recognized, “[i]t’s not just a government problem, the whole society has been targeted.”

The Finnish model includes both technical and non-technical solutions. Finnish schools stress critical thinking and media literacy, teaching students of all ages to be discerning consumers of information. The Finnish have also established a non-partisan journalistic fact-checking service: FaktaBaari. The Finnish model provides a useful starting point for a U.S. model tailored to our unique social, cultural, and legal considerations.

Technical Solutions

Detection. The plan to counter Deepfakes 2.0 must start with detection. Several companies are already developing algorithms using AI to detect deepfakes. For example, Facebook recently announced a partnership with Microsoft and academia to invest in AI systems that identify, flag, and remove harmful deepfakes. The Pentagon is also investing heavily in deepfake-detection technologies such as DARPA’s Media Forensics (MediFor) program to fight AI with AI.

Authentication. We need to establish a credible organization, perhaps through a public-private partnership, to report deepfake detection results. Blockchain technology can create digital fingerprints to help authenticate media. This technology allows videos and photos to be publicly verifiable.

Non-technical Solutions

Education. Over half of Generation Z gets its news and information primarily from social media and messaging apps on their smartphones. Therefore, schools must prioritize critical thinking and media literacy tailored to this new reality. In the decentralized American education system, this requires commitment and resources from federal, state and local governments.

Media Policy. Traditional and social media should assess criteria for evaluating suspicious or unverified, potential deepfakes that could harm society. Some social media sites have already shown a willingness to take down accounts linked to disinformation.

Legislation. Congress is considering multiple legislative proposals, including the DEEPFAKES Accountability Act. Congress should also consider a Finnish-style independent entity that provides confidence or credibility scores for digital content. State governments also play an important role. For example, California recently passed a law restricting the use of deepfakes for political purposes.

Conclusion

There is no doubt that criminals, our adversaries, and other malign actors will use deepfakes to harm the public and manipulate their sense of reality. We need a comprehensive plan to counter this threat. It requires the government, academia, and private industry to work together on both technical and non-technical solutions. Given that it is difficult to change a person’s view once it is formed, speed is a virtue when it comes to detecting deepfakes and educating the public. As the saying goes, “A lie can travel halfway around the world before truth puts on its boots.”

Source: https://www.justsecurity.org/69677/deepfakes-2-0-the-new-era-of-truth-decay/

Tags: , , , , , , ,
Posted in Datametrex AI Limited | Comments Off on Deepfakes 2.0: The New Era of “Truth Decay” – SPONSOR: Datametrex AI Limited $DM.ca

Silicon Material Produced With GEN2 PUREVAP™ Offers Promising Potential to Replace Graphite in Lithium-ion Batteries $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 10:18 AM on Wednesday, April 15th, 2020
  • Provided update on promising results emanating from electrochemical performance tests performed on materials produced with our GEN2 PUREVAPTM Quartz Reduction Reactor
  • Material produced with the GEN2 PUREVAPTM QRR, demonstrated its potential to advantageously replace graphite in Lithium-ion (Li-ion) batteries while limiting the disadvantages inherent to silicon anodes

MONTREAL, April 15, 2020  — HPQ Silicon Resources Inc.  (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; would like to update its shareholders on promising results emanating from electrochemical performance tests performed on materials produced with our GEN2 PUREVAPTM Quartz Reduction Reactor (“QRR”).

Recently, tests conducted at the Institut National de Recherche Scientifique (INRS), on material produced with the GEN2 PUREVAPTM QRR (“GEN2”), demonstrated its potential to advantageously replace graphite in Lithium-ion (Li-ion) batteries while limiting the disadvantages inherent to silicon anodes.

“While preliminary, the results obtained are very promising and validate our decision to focus our efforts on upstream production of materials needed to make the silicon-based anodes for high-density lithium-ion battery using material produced by our PUREVAPTM RRQ process as feed stock,” said Bernard Tourillon, President and CEO HPQ Silicon. “Interest in Silicon Metal’s potential to contribute to energy storage demand is undeniable and generating massive investments, as well as serious industry interest.”

SILICON (Si), A SUPERIOR ANODE MATERIAL FOR LITHIUM-ION BATTERIES VERSUS GRAPHITE

Silicon (Si) is a very promising anode material for Li-ion batteries because it’s theoretical gravimetric capacity (storage capacity in (mAh) per g of material) and volumetric capacity (storage capacity in (mAh) per cm3 of material) are significantly higher than graphite, the material currently used in commercial Li-ion batteries.  While resolving silicon swelling and cracking during the lithiation phase1 represents a significant challenge in order to achieve a comparable cyclage stability to graphite, the reference anode material of Li-ion batteries, the promising results obtained represent a step forward in that direction.

The tests on material produced with the GEN2 are part of a series of initiatives being undertaken by HPQ in order to become a producer of silicon (Si) materials suitable for the next generation Li-Ion batteries.  The tests were completed at the Centre Énergie Matériaux Télécommunications (EMT) of the INRS by Professor Lionel ROUÉ under an NSERC Engage Grant and a NSERC Engage plus Grant.

The exact composition of the material produced with the GEN2 as well as how the electrodes used in the tests were prepared are trade secrets of HPQ.  HPQ will take the necessary steps to protect this invention.  As part of this research project, HPQ retains all intellectual property rights in relation to this invention.

SILICON (Si) FOR LITHIUM-ION BATTERIES: A GROWING MARKET

A recent report by Wood Mackenzie Power projects that energy storage deployments are estimated to grow +1,300% from a 12 Gigawatt-hour market in 2018 to a 158 Gigawatt-hour market in 2024.  This is why, despite the low utilization rate of silicon-based powders in current Li-ion batteries, demand for silicon (Si) based powders is estimated to represent an addressable market of US $ 1B by 20222 expanding at a CAGR of 38.9% between 2019 – 2024.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is building a portfolio of unique high value silicon products needed for the RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
    • HPQ is in the process of becoming the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon (3N – 4N Si);
  • The PUREVAPTM Silicon Nano Reactor (SiNR), a new proprietary process that can uses different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    • HPQ objective is to become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by all the manufacturers of next-generation lithium-ion batteries;
    • During the coming months, spherical Si nanopowders and nanowires silicon-based composites samples requested by industry participants and research institutions’ will be produced using the newly upgraded Gen2 PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
    • The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

____________________
1 The incorporation of lithium into an electrode in a lithium-ion battery
2 Source Marketandmakerts.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9f7a4003-c0f6-4b77-b885-6e2b6138f49c

Silicon Vs Graphite
Gravimetric and Volumetric Capacity Silicon Versus Graphite

Tags: , , ,
Posted in All Recent Posts, Featured, HPQ-Silicon Resources Inc. | Comments Off on Silicon Material Produced With GEN2 PUREVAP™ Offers Promising Potential to Replace Graphite in Lithium-ion Batteries $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

INTERVIEW: After 478% Increase In Q1 Patients, Empower Clinics $CBDT.ca Adds Telemedicine Access To Physicians and E-Commerce $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:30 PM on Tuesday, April 14th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 800% in February. 590% in March and 480% for Q1.  But will Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower had to actually increase operating hours due to demand from existing patients who need their CBD medication more than ever, as well as, new patients who are experiencing anxiety and stress through the COVID-19 pandemic.

BUT THAT WASN’T ENOUGH

The Company has now entered expanded into telemedicine across multiple states for patients who can’t get to a clinic but need a consultation with doctors over the phone to determine the best CBD medications, as well as, 250 new homeopath products for their newly launched immunotherapy initiative …. all which can be fulfilled through the company’s e-commerce platform.

Oh …. and did we mention that psychedelics are on the way?  Empower Clinics has already announced its intention to expand into the field of Psilocybin and psychedelics.  The new telemedicine platform now accelerates this initiative.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into real growth.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Empower Clinics Inc., Featured | Comments Off on INTERVIEW: After 478% Increase In Q1 Patients, Empower Clinics $CBDT.ca Adds Telemedicine Access To Physicians and E-Commerce $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

« Older Entries
Newer Entries »